Abstract PS2-13-02: Daxx is a novel predictive biomarker of response to anti-notch plus endocrine therapy to target cancer stem cells in ER-positive breast cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: C. Osipo, D. Wyatt, P. Tang, L. Miele, K. S. Albain
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129312242
Cites:
Cited by:
Related to: